Literature DB >> 30008470

Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice.

Illana Gozes1,2, Segev Barak3,4, Yarden Ziv5,6, Nofar Rahamim6,7, Noa Lezmy6,7, Oren Even-Chen7, Ohad Shaham7, Anna Malishkevich5, Eliezer Giladi5, Ran Elkon5,6.   

Abstract

Neuroadaptations in the brain reward system caused by excessive alcohol intake, lead to drinking escalation and alcohol use disorder phenotypes. Activity-dependent neuroprotective protein (ADNP) is crucial for brain development, and is implicated in neural plasticity in adulthood. Here, we discovered that alcohol exposure regulates Adnp expression in the mesolimbic system, and that Adnp keeps alcohol drinking in moderation, in a sex-dependent manner. Specifically, Sub-chronic alcohol treatment (2.5 g/kg/day for 7 days) increased Adnp mRNA levels in the dorsal hippocampus in both sexes, and in the nucleus accumbens of female mice, 24 h after the last alcohol injection. Long-term voluntary consumption of excessive alcohol quantities (~10-15 g/kg/24 h, 5 weeks) increased Adnp mRNA in the hippocampus of male mice immediately after an alcohol-drinking session, but the level returned to baseline after 24 h of withdrawal. In contrast, excessive alcohol consumption in females led to long-lasting reduction in hippocampal Adnp expression. We further tested the regulatory role of Adnp in alcohol consumption, using the Adnp haploinsufficient mouse model. We found that Adnp haploinsufficient female mice showed higher alcohol consumption and preference, compared to Adnp intact females, whereas no genotype difference was observed in males. Importantly, daily intranasal administration of the ADNP-snippet drug candidate NAP normalized alcohol consumption in Adnp haploinsufficient females. Finally, female Adnp haploinsufficient mice showed a sharp increase in alcohol intake after abstinence, suggesting that Adnp protects against relapse in females. The current data suggest that ADNP is a potential novel biomarker and negative regulator of alcohol-drinking behaviors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30008470      PMCID: PMC6300527          DOI: 10.1038/s41386-018-0132-7

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  6 in total

1.  An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.

Authors:  I Gozes; S K McCune; L Jacobson; D Warren; T W Moody; M Fridkin; D E Brenneman
Journal:  J Pharmacol Exp Ther       Date:  1991-06       Impact factor: 4.030

2.  Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome.

Authors:  C Y Spong; D T Abebe; I Gozes; D E Brenneman; J M Hill
Journal:  J Pharmacol Exp Ther       Date:  2001-05       Impact factor: 4.030

3.  Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze.

Authors:  I Gozes; E Giladi; A Pinhasov; A Bardea; D E Brenneman
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

4.  Ethanol-induced ligand-independent activation of ERalpha mediated by cyclic AMP/PKA signaling pathway: an in vitro study on MCF-7 breast cancer cells.

Authors:  Nicolas Etique; Stephane Flament; Julie Lecomte; Isabelle Grillier-Vuissoz
Journal:  Int J Oncol       Date:  2007-12       Impact factor: 5.650

5.  Ethanol, nicotine, amphetamine, and aspartame consumption and preferences in C57BL/6 and DBA/2 mice.

Authors:  C J Meliska; A Bartke; G McGlacken; R A Jensen
Journal:  Pharmacol Biochem Behav       Date:  1995-04       Impact factor: 3.533

6.  Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP.

Authors:  Anke Van Dijck; Anneke T Vulto-van Silfhout; Elisa Cappuyns; Ilse M van der Werf; Grazia M Mancini; Andreas Tzschach; Raphael Bernier; Illana Gozes; Evan E Eichler; Corrado Romano; Anna Lindstrand; Ann Nordgren; Malin Kvarnung; Tjitske Kleefstra; Bert B A de Vries; Sébastien Küry; Jill A Rosenfeld; Marije E Meuwissen; Geert Vandeweyer; R Frank Kooy
Journal:  Biol Psychiatry       Date:  2018-03-15       Impact factor: 13.382

  6 in total
  5 in total

1.  Neuroprotective Peptide NAPVSIPQ Antagonizes Ethanol Inhibition of L1 Adhesion by Promoting the Dissociation of L1 and Ankyrin-G.

Authors:  Xiaowei Dou; Jerry Y Lee; Michael E Charness
Journal:  Biol Psychiatry       Date:  2019-09-05       Impact factor: 13.382

Review 2.  Alcohol and the brain: from genes to circuits.

Authors:  Gabor Egervari; Cody A Siciliano; Ellanor L Whiteley; Dorit Ron
Journal:  Trends Neurosci       Date:  2021-10-23       Impact factor: 13.837

3.  Inhibition of FGF Receptor-1 Suppresses Alcohol Consumption: Role of PI3 Kinase Signaling in Dorsomedial Striatum.

Authors:  Oren Even-Chen; Segev Barak
Journal:  J Neurosci       Date:  2019-08-02       Impact factor: 6.167

4.  Sex-and Region-Dependent Expression of the Autism-Linked ADNP Correlates with Social- and Speech-Related Genes in the Canary Brain.

Authors:  Gal Hacohen-Kleiman; Stan Moaraf; Oxana Kapitansky; Illana Gozes
Journal:  J Mol Neurosci       Date:  2020-09-14       Impact factor: 3.444

Review 5.  The ADNP Syndrome and CP201 (NAP) Potential and Hope.

Authors:  Illana Gozes
Journal:  Front Neurol       Date:  2020-11-24       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.